Neuberger Berman Group LLC Pfizer Inc Transaction History

Neuberger Berman Group LLC

$118 Billion
Q1 2024

A detailed history of Neuberger Berman Group LLC transactions in Pfizer Inc stock. As of the latest transaction made, Neuberger Berman Group LLC holds 15,252,383 shares of PFE stock, worth $437 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

15,252,383

Holding current value

$437 Million

% of portfolio

0.36%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $395 Million - $453 Million	15,252,383 New	15,252,383 $423 Million
Q4 2023 Feb 09, 2024	BUY	$26.13 - $33.94 $17.4 Million - $22.6 Million	666,784 Added 3.91%	17,702,349 $510 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $106 Million - $123 Million	3,292,002 Added 23.95%	17,035,565 $565 Million
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $1.98 Million - $2.3 Million	-54,920 Reduced 0.4%	13,743,563 $504 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $57.4 Million - $74.7 Million	1,456,337 Added 11.8%	13,798,483 $563 Million

Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $38.9 Million - $50.8 Million	-931,535 Reduced 7.02%	12,342,146 $633 Million
Q3 2022 Nov 15, 2022	BUY	$43.76 - $53.42 $46.5 Million - $56.7 Million	1,061,894 Added 8.7%	13,273,681 $581 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $103 Million - $122 Million	2,208,244 Added 22.07%	12,211,787 $640 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $22.9 Million - $28.3 Million	499,802 Added 5.26%	10,003,543 $513 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $4.95 Million - $7.34 Million	119,903 Added 1.28%	9,503,741 $556 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $32.5 Million - $41.8 Million	828,318 Added 9.68%	9,383,838 $401 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $119 Million - $135 Million	3,317,439 Added 63.33%	8,555,520 $334 Million
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $34.8 Million - $39.3 Million	-1,039,370 Reduced 16.56%	5,238,081 $189 Million
Q4 2020 Feb 10, 2021	SELL	$33.47 - $42.56 $16.8 Million - $21.4 Million	-503,307 Reduced 7.42%	6,277,451 $231 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $16.8 Million - $19.7 Million	-528,821 Reduced 7.23%	6,780,758 $236 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $21 Million - $25.4 Million	-695,922 Reduced 8.69%	7,309,579 $239 Million
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $19.3 Million - $27.6 Million	-715,748 Reduced 8.21%	8,005,501 $248 Million
Q4 2019 Feb 12, 2020	SELL	$32.92 - $37.36 $58.6 Million - $66.5 Million	-1,779,890 Reduced 16.95%	8,721,249 $342 Million
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $37 Million - $48 Million	-1,138,695 Reduced 9.78%	10,501,139 $377 Million
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $28.4 Million - $31.9 Million	-768,736 Reduced 6.2%	11,639,834 $504 Million
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $34.9 Million - $38.3 Million	-930,398 Reduced 6.98%	12,408,570 $527 Million
Q4 2018 Feb 12, 2019	SELL	$38.47 - $43.86 $39.3 Million - $44.8 Million	-1,022,438 Reduced 7.12%	13,338,968 $582 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $28.2 Million - $34.2 Million	-818,602 Reduced 5.39%	14,361,406 $633 Million
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $28.9 Million - $30.8 Million	-876,102 Reduced 5.46%	15,180,008 $551 Million
Q1 2018 May 08, 2018	BUY	$31.91 - $37.02 $77.6 Million - $90.1 Million	2,432,694 Added 17.86%	16,056,110 $570 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $25 Million - $26.5 Million	-751,529 Reduced 5.23%	13,623,416 $494 Million
Q3 2017 Nov 15, 2017	BUY	$31.0 - $34.15 $446 Million - $491 Million	14,374,945	14,374,945 $513 Million

Others Institutions Holding PFE

# of Institutions

3,154

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $161B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Pfizer Inc Transaction History